In addition to these Hyal1 and/or testicular hyaluronidase inhibitors, the panel also included ipriflavone, an isoflavone that has been suggested to influence HA metabolism in CEMIP-expressing chondrosarcoma cells [36]. The gene discussed is HYAL1; the disease is chondrosarcoma.